DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Chow R, Chiu L, Herrstedt J. et al
Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in highly emetogenic chemotherapy (HEC) patients.
Support Care Cancer 2021;
29 (08) 4269-4275
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.